A multicenter, randomized, double-blind, placebo-based parallel-controlled clinical study of Bushen Huoxue Decoction for treatment of coronary heart disease in stable angina pectoris with kidney deficiency and blood stasis syndrome

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Experimental group:Bushen Huoxue Granules + Conventional Western Medicine;Control group:Placebo Granules + conventional Western medicine; CONDITION: Coronary heart disease in stable angina pectoris PRIMARY OUTCOME: The effect of coronary heart disease and angina pectoris; SECONDARY OUTCOME: The effect of TCM Syndromes of coronary heart disease and angina pectoris;Stop and decrease of nitroglycerin;ECG efficacy;Seattle Angina Questionnaiire;Blood lipid efficacy;Cardiovascular endpoint;Safety evaluation; INCLUSION CRITERIA: 1. Follow the diagnostic criteria for stable angina pectoris of coronary heart disease; 2. Patients who diagnosed with kidney deficiency and blood stasis syndrome by TCM syndromes; 3. Patients aged between 40 and 80 years; 4. Patients who voluntarily sign the informed consent.
Epistemonikos ID: 394932d7f37579529eb97953a9fb23f7e6e52460
First added on: Feb 20, 2024